“ I must appreciate StemCyte India’s efforts, against all odds, to build an inventory of Cord Blood units in the Public domain, made available for use for patients suffering from life-threatening diseases. I have used StemCyte’s cord blood units and the Patented Cord Blood processing technology surely ensures very good cell dose besides the viability at the time of transplant. When it comes to using Cord Blood as life-saving therapeutic modality, the biggest hurdle is finance, as evident from the statistics. I must appreciate your sincere efforts to keep the price to minimum and affordable to our patients. ”